Olaparib as maintenance treatment in patients with chemosensitive small cell lung cancer (STOMP): a randomised, double-blind, placebo-controlled phase II trial
Penella Woll, Piers Gaunt, Sarah Danson*, Nicola Steele, Samreen Ahmed, Clive Mulatero, Riyaz Shah, Jaishree Bhosle, Elizabeth Hodgkinson, Ben Watkins, Lucinda Billingham
Research output: Contribution to journal › Article › peer-review
145Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Olaparib as maintenance treatment in patients with chemosensitive small cell lung cancer (STOMP): a randomised, double-blind, placebo-controlled phase II trial'. Together they form a unique fingerprint.